查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1507220

搔痒治疗药物市场、占有率、规模、趋势、产业分析报告：依疾病类型、产品、地区、细分市场预测，2024-2032年

Pruritus Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Allergic Contact Dermatitis, Atopic Dermatitis, Urticaria, Others); By Product; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，预计到2032年全球止痒药物市场规模将达到132亿美元。本研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

由于与各种皮肤和全身性疾病相关的慢性搔痒的盛行率不断增加，搔痒治疗药物市场显着成长。人们越来越认识到搔痒对患者的生活品质有重大影响，增加了对有效治疗方案的需求。医学的进步，特别是新生物製剂和标靶疗法的发明，日益扩大搔痒症的治疗范围，并改善患者的治疗效果。此外，全球人口老化，更容易感染引起持续性搔痒的疾病，进一步推动了市场成长。

主要市场趋势包括开发和使用专门针对搔痒分子机制的生物和免疫调节剂。此外，越来越多的运动采用先进的药物传递系统来提高局部治疗的有效性和黏附力。

皮肤病发生率的增加是搔痒治疗药物市场的主要驱动因素。这些疾病常表现为慢性搔痒，对患者的生活品质有重大影响。都市化、污染和生活方式的改变等因素导致湿疹、牛皮癣和异位性皮肤炎等皮肤病在全球的盛行率增加，导致皮肤屏障受损和免疫力受损。此外，主要製药公司和新兴生技公司之间的激烈竞争也是搔痒治疗药物市场竞争格局的特征。这些业界领先的公司利用先进的生物製剂、免疫调节剂和标靶疗法来开发创新疗法，解决搔痒的根本原因。

搔痒治疗药物市场报告亮点

2023年全球止痒药物市场主要由异位性皮肤炎市场驱动，因为该市场患病率高且长期存在。异位性皮肤炎的主要症状往往是严重且持续的搔痒。

2023年搔痒治疗药物市场，皮质类固醇的销售占有率最高。这主要是由于皮质类固醇在治疗引起皮肤搔痒的各种发炎性皮肤病的广泛使用和已确立的疗效。

2023年，由于异位性皮肤炎、牛皮癣和湿疹等皮肤病的高发，北美成为全球市场的关键地区。这些疾病大幅推动了该地区对搔痒治疗的需求。

目录

第1章 简介

第2章 执行摘要

第3章 研究方法

第4章 全球搔痒治疗药物市场洞察

  • 行业概况
  • 搔痒药物市场动态
    • 推动因素和机会
      • 皮肤病盛行率增加
      • 生物技术与药理学的进展
    • 抑制因素和挑战
      • 副作用与安全性问题
  • PESTLE分析
  • 搔痒治疗药物产业的趋势
  • 价值链分析
  • 新冠肺炎（COVID-19）影响分析

第5章 全球搔痒治疗药物市场：依疾病类型

  • 主要发现
  • 简介
  • 过敏性接触性皮肤炎
  • 异位性皮肤炎
  • 荨麻疹
  • 其他

第6章 全球搔痒治疗药物市场：依产品

  • 主要发现
  • 简介
  • 抗组织胺药
  • 钙调神经磷酸酶抑制剂
  • 皮质类固醇
  • 抗刺激剂
  • 免疫抑制剂
  • 局部麻醉剂
  • 其他

第7章 全球搔痒治疗药物市场：依地区

  • 主要发现
  • 简介
    • 搔痒治疗药物市场评估：依地区，2019-2032
  • 北美
    • 北美：依产品分类，2019-2032年
    • 北美：依疾病类型，2019-2032年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：依产品分类，2019-2032年
    • 欧洲：依疾病类型，2019-2032年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
  • 亚太地区
    • 亚太地区：依产品分类，2019-2032年
    • 亚太地区：依疾病类型，2019-2032年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
  • 中东、非洲
    • 中东与非洲：依产品分类，2019-2032年
    • 中东与非洲：依疾病类型，2019-2032年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依产品分类，2019-2032年
    • 拉丁美洲：依疾病类型，2019-2032年
    • 墨西哥
    • 巴西
    • 阿根廷

第8章 竞争态势

  • 扩张与收购分析
    • 扩张
    • 收购
  • 伙伴关係/协作/协定/揭露

第9章 公司简介

  • AbbVie Inc
  • Amgen Inc
  • Astellas Pharma Inc
  • Bristol Myers Squibb
  • Cara Therapeutics
  • GSK plc
  • Novartis AG
  • Pfizer Inc
  • Sanofi
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc
Product Code: PM1301

The global Pruritus Therapeutics market size is expected to reach USD 13.2 Billion by 2032, according to a new study by Polaris Market Research. The report "Pruritus Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Allergic Contact Dermatitis, Atopic Dermatitis, Urticaria, Others); By Product; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market for treating pruritus is seeing significant growth as a result of the increasing prevalence of chronic itching linked to various skin and systemic conditions. The growing awareness of pruritus's substantial impact on patient's quality of life is boosting the demand for effective treatment options. Advances in pharmaceuticals, particularly the creation of new biologics and targeted therapies, are broadening the range of treatments available for pruritus, leading to better patient outcomes. Additionally, the aging global population, which is more prone to conditions causing persistent itching, is further propelling market growth.

Key trends in the market include the development and use of biological drugs and immunomodulators that specifically target the molecular mechanisms underlying pruritus. The incorporation of advanced drug delivery systems to improve the effectiveness and adherence of topical treatments is also gaining momentum.

The rising incidence of dermatological disorders is a key driver for the pruritus therapeutics market. These conditions often manifest as chronic itching, significantly impacting patients' quality of life. Factors such as urbanization, pollution, and lifestyle changes contribute to the increasing global prevalence of skin diseases like eczema, psoriasis, and atopic dermatitis, resulting in compromised skin barriers and immune system changes. Furthermore, intense competition among major pharmaceutical companies and emerging biotech firms characterize the competitive landscape of the pruritus therapeutics market. These industry leaders are leveraging advanced biologics, immunomodulators, and targeted therapies to develop innovative treatments that address the root causes of pruritus.

Pruritus Therapeutics Market Report Highlights

The global market for pruritus therapeutics in 2023 was primarily driven by the atopic dermatitis segment, owing to the condition's high prevalence and chronicity. This condition is often characterized by severe and persistent itching as a primary symptom.

The corticosteroids segment had the highest revenue share in the pruritus therapeutics market in 2023. This was primarily due to their extensive utilization and established effectiveness in treating various inflammatory skin conditions that result in pruritus.

In 2023, North America established itself as the leading region in the global market due to its high prevalence of dermatological conditions like atopic dermatitis, psoriasis, and eczema. These conditions have significantly boosted the demand for pruritus treatments in the region.

The global key market players include AbbVie Inc., Amgen Inc., Astellas Pharma Inc., Bristol Myers Squibb, Cara Therapeutics, GSK plc, Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Viatris Inc., among others.

Polaris Market Research has segmented the pruritus therapeutics market report based on disease type, product, and region:

Pruritus Therapeutics, Disease Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Allergic Contact Dermatitis
  • Atopic Dermatitis
  • Urticaria
  • Othersc

Pruritus Therapeutics, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Antihistamines
  • Calcineurin Inhibitors
  • Corticosteroids
  • Counterirritants
  • Immunosuppressant
  • Local Anesthetics
  • Others

Pruritus Therapeutics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Pruritus Therapeutics Market Insights

  • 4.1. Pruritus Therapeutics Market - Industry Snapshot
  • 4.2. Pruritus Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence of Dermatological Conditions
      • 4.2.1.2. Advances in Biotechnology and Pharmacology
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Adverse Effects and Safety Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Pruritus Therapeutics Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Pruritus Therapeutics Market, by Disease Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Pruritus Therapeutics, by Disease Type, 2019-2032 (USD Billion)
  • 5.3. Allergic Contact Dermatitis
    • 5.3.1. Global Pruritus Therapeutics Market, by Allergic Contact Dermatitis, by Region, 2019-2032 (USD Billion)
  • 5.4. Atopic Dermatitis
    • 5.4.1. Global Pruritus Therapeutics Market, by Atopic Dermatitis, by Region, 2019-2032 (USD Billion)
  • 5.5. Urticaria
    • 5.5.1. Global Pruritus Therapeutics Market, by Urticaria, by Region, 2019-2032 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Pruritus Therapeutics Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Pruritus Therapeutics Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • 6.3. Antihistamines
    • 6.3.1. Global Pruritus Therapeutics Market, by Antihistamines, by Region, 2019-2032 (USD Billion)
  • 6.4. Calcineurin Inhibitors
    • 6.4.1. Global Pruritus Therapeutics Market, by Calcineurin Inhibitors, by Region, 2019-2032 (USD Billion)
  • 6.5. Corticosteroids
    • 6.5.1. Global Pruritus Therapeutics Market, by Corticosteroids, by Region, 2019-2032 (USD Billion)
  • 6.6. Counterirritants
    • 6.6.1. Global Pruritus Therapeutics Market, by Counterirritants, by Region, 2019-2032 (USD Billion)
  • 6.7. Immunosuppressant
    • 6.7.1. Global Pruritus Therapeutics Market, by Immunosuppressant, by Region, 2019-2032 (USD Billion)
  • 6.8. Local Anesthetics
    • 6.8.1. Global Pruritus Therapeutics Market, by Local Anesthetics, by Region, 2019-2032 (USD Billion)
  • 6.9. Others
    • 6.9.1. Global Pruritus Therapeutics Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Pruritus Therapeutics Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Pruritus Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Pruritus Therapeutics Market - North America
    • 7.3.1. North America: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.3.2. North America: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.3.3. Pruritus Therapeutics Market - U.S.
      • 7.3.3.1. U.S.: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.3.4. Pruritus Therapeutics Market - Canada
      • 7.3.4.1. Canada: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • 7.4. Pruritus Therapeutics Market - Europe
    • 7.4.1. Europe: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.3. Pruritus Therapeutics Market - UK
      • 7.4.3.1. UK: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.4. Pruritus Therapeutics Market - France
      • 7.4.4.1. France: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.5. Pruritus Therapeutics Market - Germany
      • 7.4.5.1. Germany: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.6. Pruritus Therapeutics Market - Italy
      • 7.4.6.1. Italy: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.7. Pruritus Therapeutics Market - Spain
      • 7.4.7.1. Spain: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.8. Pruritus Therapeutics Market - Netherlands
      • 7.4.8.1. Netherlands: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.9. Pruritus Therapeutics Market - Russia
      • 7.4.9.1. Russia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • 7.5. Pruritus Therapeutics Market - Asia Pacific
    • 7.5.1. Asia Pacific: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.3. Pruritus Therapeutics Market - China
      • 7.5.3.1. China: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.4. Pruritus Therapeutics Market - India
      • 7.5.4.1. India: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.5. Pruritus Therapeutics Market - Malaysia
      • 7.5.5.1. Malaysia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.6. Pruritus Therapeutics Market - Japan
      • 7.5.6.1. Japan: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.7. Pruritus Therapeutics Market - Indonesia
      • 7.5.7.1. Indonesia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.8. Pruritus Therapeutics Market - South Korea
      • 7.5.8.1. South Korea: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • 7.6. Pruritus Therapeutics Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.6.3. Pruritus Therapeutics Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.6.4. Pruritus Therapeutics Market - UAE
      • 7.6.4.1. UAE: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.6.5. Pruritus Therapeutics Market - Israel
      • 7.6.5.1. Israel: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.6.6. Pruritus Therapeutics Market - South Africa
      • 7.6.6.1. South Africa: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • 7.7. Pruritus Therapeutics Market - Latin America
    • 7.7.1. Latin America: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.7.3. Pruritus Therapeutics Market - Mexico
      • 7.7.3.1. Mexico: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.7.4. Pruritus Therapeutics Market - Brazil
      • 7.7.4.1. Brazil: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.7.5. Pruritus Therapeutics Market - Argentina
      • 7.7.5.1. Argentina: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. AbbVie Inc
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Amgen Inc
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Astellas Pharma Inc
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Bristol Myers Squibb
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Cara Therapeutics
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. GSK plc
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Novartis AG
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Pfizer Inc
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Sanofi
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Teva Pharmaceutical Industries Ltd
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Viatris Inc
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development

List of Tables

  • Table 1 Global Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 2 Global Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 3 Pruritus Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 5 North America: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 6 U.S.: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 7 U.S.: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 8 Canada: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 9 Canada: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 10 Europe: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 11 Europe: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 12 UK: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 13 UK: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 14 France: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 15 France: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 16 Germany: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 17 Germany: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 18 Italy: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 19 Italy: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 20 Spain: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 21 Spain: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 24 Russia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 25 Russia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 28 China: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 29 China: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 30 India: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 31 India: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 34 Japan: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 35 Japan: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 38 South Korea: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 39 South Korea: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 44 UAE: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 45 UAE: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 46 Israel: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 47 Israel: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 48 South Africa: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 49 South Africa: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 50 Latin America: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 51 Latin America: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 52 Mexico: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 53 Mexico: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 54 Brazil: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 55 Brazil: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 56 Argentina: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 57 Argentina: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Pruritus Therapeutics Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Product
  • Figure 7 Global Pruritus Therapeutics Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Disease Type
  • Figure 9 Global Pruritus Therapeutics Market, by Disease Type, 2022 & 2032 (USD Billion)
  • Figure 10 Pruritus Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Pruritus Therapeutics Market